Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn's disease

Joachim Høg Mortensen  1     Morten Asser Karsdal  1     Henning Grønbæk  2     Christian Lodberg Hvas  2     Anders Dige  2     Tina Manon-Jensen  1    
1 Nordic Bioscience,Herlev,Denmark
2 Aarhus University Hospital,Aarhus,Denmark

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing